Diagnostic and Biotech

Protein Labeling Market by Labeling Method [In Vitro (Nanoparticle, Site-Specific, Dye-Based, Co-Translational, and Enzymatic Labeling) and In Vivo (Radioactive, and Photoreactive Labeling), and Bioorthogonal Labeling], Application (Cell-Based Assays, Fluorescence Microscopy, Mass Spectrometry, Immunological Techniques, and Protein Microarray), Product Type [Kits, Reagents (Enzymes, Monoclonal Antibodies, Probes/Tags, Protein, and Other Reagents), and Services], and End Users (Research Laboratories, Hospitals and Diagnostic Centers, and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • ALL807599
  • 160 Pages
  • December 2016
  • Diagnostic and Biotech

Protein labeling is a process in biological research that uses molecular labels to create covalent bonds with the protein of interest. This helps in the detection and purification of the labeled protein and/or its binding associates. The process is carried out with the use of different labels such as, biotin, reporter enzymes, monoclonal antibodies, fluorophores, radioactive isotopes, and other tags. Specific labels are used to target a particular protein or nucleotide sequence and the labeling strategy is carefully selected and completed for each application. This process is helpful to identify proteins in tissues, cells, samples, and biochemical assays. The increase in healthcare and R&D expenditure and progress in proteomics research primarily drive the protein labeling market.

This market is estimated to reach $5,350 million by 2022 from $2,002 million in 2015, growing at a significant CAGR of 14.9% during the forecast period. Moreover, government investments on healthcare and R&D on the increase in the use of proteomics, and other applications such as diagnostics and therapeutics are expected to drive the market. However, lack of skilled professionals and accelerated market consolidation is expected to restrict the market growth.

The growth in competition has led to collaborations and product launch by major players in the protein labeling market. For instance, in September 2016, Kaneka Corporation’s subsidiary, Eurogentec S.A. signed an agreement with Koram Biotech Corp. (KBC), one of the largest life science reagent and services companies in South Korea, to be the new distributor for its products. This collaboration has helped Kaneka to make a smooth entry in the South Korean market. Likewise, in June 2016, F. Hoffmann-LA Roche AG (Roche) launched a new product, Cobas E 801 module, a high-volume testing immunoassay solution that had high flexibility and continuous operation, which saves time and reduces the amount of waste generated during the process.

KEY BENEFITS

  • The global protein labeling market report provides an extensive analysis of the current market trends and future estimations prevailing in the market.
  • The market estimations from 2014 to 2022 are based on high-end analysis of the key developments.
  • The market scenario is comprehensively analyzed with respect to the application, product type, labeling method, and end users.
  • Recent developments and key manufacturers are listed and analyzed to understand the competitive market scenario.
  • In-depth analysis, based on geography provides an understanding of the regional market, which assists in strategic business planning.

KEY MARKET SEGMENTS

By Labeling Method

  • In Vitro Labeling
  • Nanoparticle Labeling
  • Site-Specific Labeling
  • Dye-Based Labeling
  • Co-Translational Labeling
  • Enzymatic Labeling
  • In Vivo Labeling
  • Radioactive Labeling
  • Photoreactive Labeling
  • Bioorthogonal Labeling

By Application

  • Cell-Based Assays
  • Fluorescence Microscopy
  • Mass Spectrometry
  • Immunological Techniques
  • Protein Microarray

By Product Type

  • Kits
  • Reagents
  • Enzymes
  • Monoclonal Antibodies
  • Probes/Tags
  • Protein
  • Other Reagents
  • Services

By End Users

  • Research Laboratories
  • Hospitals and Diagnostic Centers
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Republic of South Africa
    • Rest of LAMEA

The key players profiled in this report include:

  • General Electric Company
  • Kaneka Corporation
  • LI-COR, Inc.
  • Merck & Co., Inc.
  • New England Biolabs, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • F. Hoffmann-LA Roche AG
  • Seracare Life Sciences, Inc.
  • Thermo Fisher Scientific, Inc.

The other players of the protein labeling market include (companies not profiled in the report):

  • Qiagen N.V.
  • Active Motif, Inc.
  • Takara Bio USA, Inc.
  • Candor Bioscience GMBHa
  • Innova Biosciences Ltd.
  • Luminex Corporation
  • Bio-Rad Laboratories
  • Agilent Technologies, Inc.
  • Caprion Biosciences
  • Nanotemper Technologies GMBH
  • Biotium, Inc.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

2017 © Copyright Big Market Research

View Pricing >>